Oleg L. Serov
Siberian Branch
Novosibirsk, NVS, Russian Federation
Novosibirsk, NVS, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants.
Journal: Frontiers in immunology
Published: June 01, 2024
The human EF1a promoter does not provide expression of the transgene in mice.
Journal: Transgenic research
Published: May 16, 2022
Generation of iPS cell line (ICGi040-A) from skin fibroblasts of a patient with ring small supernumerary marker chromosome 4.
Journal: Stem cell research
Published: February 14, 2022
Evaluation of the α-casein (CSN1S1) locus as a potential target for a site-specific transgene integration.
Journal: Scientific reports
Published: November 06, 2021
Creation of transgenic mice susceptible to coronaviruses: a platform for studying viral pathogenesis and testing vaccines.
Journal: Vavilovskii zhurnal genetiki i selektsii
Published: March 25, 2021
Establishment of an induced pluripotent stem cell line (ICGi026-A) from peripheral blood mononuclear cells of a patient with fragile X syndrome.
Journal: Stem cell research
Published: October 01, 2020
Generation of iPSC line ICGi024-A from human skin fibroblasts of a patient with ring chromosome 18.
Journal: Stem cell research
Published: September 25, 2020
Establishment of an induced pluripotent stem cell line (ICGi025-A) from fibroblasts of a patient with 46,XY,r(8)/45,XY,-8 mosaicism.
Journal: Stem cell research
Published: August 01, 2020
Generation of the induced pluripotent stem cell line, ICAGi002-A, from unaffected carrier megabase scaled duplication involving the CNTN6 gene.
Journal: Stem cell research
Published: August 12, 2019
Last Updated: 09/26/2026